View in EDS HTML Full Text PDF Full Text

Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real‐life clinical practice.

Saved in:
Bibliographic Details
Title: Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real‐life clinical practice.
Authors: Butrón‐Bris, B.1 (AUTHOR), Llamas‐Velasco, M.1 (AUTHOR), Ovejero‐Benito, M. C.2 (AUTHOR), Santos‐Juanes, J.3,4 (AUTHOR), Martínez‐López, A.5 (AUTHOR), Ruiz‐Villaverde, R.6 (AUTHOR), Roustan, G.7 (AUTHOR), Baniandrés, O.8 (AUTHOR), Izu‐Belloso, R.9 (AUTHOR), de la Cueva, P.10 (AUTHOR), Sahuquillo‐Torralba, A.11 (AUTHOR), Gónzalez‐Quesada, A.12 (AUTHOR), Vilarrasa‐Rull, E.13 (AUTHOR), Pujol‐Montcusí, J.14 (AUTHOR), García‐Martínez, J.15 (AUTHOR), Navares, M.16 (AUTHOR), Palomar‐Moreno, I.17 (AUTHOR), Novalbos, J.16 (AUTHOR), Abad‐Santos, F.16 (AUTHOR), Daudén, E.1 (AUTHOR)
Source: Experimental Dermatology. Aug2024, Vol. 33 Issue 8, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09066705
DOI:10.1111/exd.15152